missing translation for 'onlineSavingsMsg'
Få mere at vide

Tocris Bioscience™ GSK 215
GREENER_CHOICE

Artikelnummer. 18706285
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
18706285 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 18706285 Leverandør Tocris Bioscience™ Leverandørnr. 7818/5

Please to purchase this item. Need a web account? Register with us today!

Denne vare kan ikke returneres. Se returpolicy

Potent and selective focal adhesion kinase (FAK) degrader

GSK 215 is a potent and selective focal adhesion kinase (FAK) Degrader (PROTAC™; pDC50 = 8.4, last for 96 h). Comprises the FAK inhibitor, PND 1186 (Cat. No. 6891), joined by a linker to a VHL E3 ligase ligand. Kinome binding (KinoBead profiling) shows GSK 215 (at 10 nM) has high selectivity for the FAK kinase domain. GSK 215 inhibits cell proliferation in MCF-7 and A549 cells and suppresses A549 cell motility in a wound scratch model system. In CD1 mice, GSK 215 injection induces rapid and profound degradation of FAK in liver (Dmax = 85% at 18h).
TRUSTED_SUSTAINABILITY

Tekniske data

Kemisk navn eller materiale (2 S,4 R)-4-Hydroxy-1-(-2-(2-(4-(3-methoxy-4-((4-((2-(methylcarbamoyl)phenyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-N-(-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
CAS 2743427-26-9
Mængde 5 mg
Mål Active Degraders
Molekylær formel C50H59F3N10O6S
Renhed 0.98
Produkttitel
Vælg et problem

Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.